Kathleen E. Walsh - 15 Dec 2022 Form 4 Insider Report for LifeMD, Inc. (LFMD)

Reporting relationship: Director
Issuer ticker: LFMD
Reported as of: 15 Dec 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Dec 2022, 11:44:47 UTC
Prior SEC filing: 02 Sep 2022
Next SEC filing: 08 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Kate Walsh

Key filing fact

Kathleen E. Walsh filed Form 4 for LifeMD, Inc. (LFMD) on 23 Dec 2022.

Key facts

This page summarizes Kathleen E. Walsh's Form 4 filing for LifeMD, Inc. (LFMD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Dec 2022, 11:44.

Change

Previous filing in this sequence was filed on 02 Sep 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFMD transaction

Common Stock

Award

Transaction value
Shares: +75,000
Change %
Price
Shares after: 75,000
Date: 15 Dec 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LFMD transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +37,500
Change %
Price: $0.000000
Shares after: 37,500
Date: 15 Dec 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,500
Exercise price: $2.30
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the Director received a one-time grant of 75,000 restricted shares, with 37,500 shares vesting immediately and the remaining 37,500 shares vesting on December 15, 2024.

Footnote F2

The option vests on December 15, 2024.